Benjamin R. Cowen

Director/Board Member at INCON CO.,LTD.

63 year

Health Technology

Consumer Services

Consumer Durables

Profile

Benjamin R.
Cowen is currently the President & Chief Executive Officer at ImmunoMet Therapeutics, Inc. He is also a Director at INCON Co., Ltd.
and has been a Director at Atrin Pharmaceuticals LLC since 2012.
Previously, he served as the Vice President-Corporate Development at Milestone Pharmaceuticals, Inc. Dr. Cowen holds an MBA degree from Carnegie Mellon University, which he obtained in 1997.
He also holds a doctorate degree from the University of Illinois, which he received in 1990.

Benjamin R. Cowen active positions

Companies	Position	Start
INCON CO.,LTD.	Director/Board Member	-
Atrin Pharmaceuticals LLC Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.	Director/Board Member	31/12/2011
ImmunoMet Therapeutics, Inc. ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX.	Chief Executive Officer	31/10/2017

All active positions of Benjamin R. Cowen

Former positions of Benjamin R. Cowen

Companies	Position	End
MILESTONE PHARMACEUTICALS INC.	Corporate Officer/Principal	-

See the detail of Benjamin R. Cowen's experience

Training of Benjamin R. Cowen

Carnegie Mellon University	Masters Business Admin
University of Illinois	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Benjamin R. Cowen's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
MILESTONE PHARMACEUTICALS INC.	Health Technology
INCON CO.,LTD.	Consumer Durables

Private companies	2
Atrin Pharmaceuticals LLC Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.	Health Technology
ImmunoMet Therapeutics, Inc. ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX.	Health Technology